It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 | Mumbai, Maharashtra, India | ActiveIndo Safe Pharma Private Limited, a active private limited company, was established on 21 August 2017 in Mumbai, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2017PTC298797. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 74 professional, Its leadership includes Jai Kumar Mittal (Director), Sanjay Mittal (Director), Shailesh Mittal (Director). Its latest AGM occurred on 05 August 2025, with the balance sheet filed on 31 March 2025. It is based at 103, Kiran Building - D, Parsi Panchayat Road, Near Sona Udyog, Mogra Village, Mumbai, Maharashtra, 400069.
U74999MH2017PTC298797
298797
21 August 2017
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Indo Safe Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jai Kumar Mittal | Director | 21 Aug 2017 | Current |
| Sanjay Mittal | Director | 21 Aug 2017 | Current |
| Shailesh Mittal | Director | 21 Aug 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indo Safe Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2298.07% increase. The company also saw a substantial improvement in profitability, with a 1231.38% increase in profit. The company's net worth Soared by an impressive increase of 4542.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Indo Safe Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Indo Safe Pharma has a workforce of 74 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indo Safe Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo Safe Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Indo Safe Pharma Private Limited last Annual general meeting of members was held on 05 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on Indo Safe Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Jai Kumar Mittal was appointed as a Director was appointed as a Director on 21 Aug 2017 & has been associated with this company since 8 years 4 months . was completed.
Progress on Sanjay Mittal was appointed as a Director was appointed as a Director on 21 Aug 2017 & has been associated with this company since 8 years 4 months . was documented.
Progress on Shailesh Mittal was appointed as a Director was appointed as a Director on 21 Aug 2017 & has been associated with this company since 8 years 4 months . was documented.
Indo Safe Pharma Private Limited was registered on 21 Aug 2017 with Roc Mumbai & aged 8 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Indo Safe Pharma Private Limited is U74999MH2017PTC298797.
Indo Safe Pharma Private Limited is headquartered at 103, Kiran Building - D, Parsi Panchayat Road, Near Sona Udyog, Mogra Village, Mumbai, Maharashtra, 400069.
Indo Safe Pharma Private Limited was incorporated on 21 August 2017.
The current directors of Indo Safe Pharma Private Limited are
The primary industry of Indo Safe Pharma Private Limited is Business Services.
Indo Safe Pharma Private Limited is unlisted.
The authorized capital of Indo Safe Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Indo Safe Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX